Literature DB >> 1331499

Immunological characterization of the gag gene products of bovine immunodeficiency virus.

J K Battles1, M Y Hu, L Rasmussen, G J Tobin, M A Gonda.   

Abstract

The bovine immunodeficiency virus (BIV) gag gene encodes a 53-kDa precursor (Pr53gag) that is involved in virus particle assembly and is further processed into the putative matrix (MA), capsid (CA), and nucleocapsid (NC) functional domains in the mature virus. Gag determinants are also found in the Gag-Pol polyprotein precursor. To immunologically identify the major precursors and processed products of the BIV gag gene, monospecific rabbit sera to recombinant BIV MA protein and Pr53gag and peptides predicted to correspond to the CA and NC proteins and the MA-CA cleavage site were developed and used in immunoprecipitations and immunoblots of BIV antigens. Monospecific antisera to native and recombinant human immunodeficiency virus type 1 proteins were also used to identify analogous BIV Gag proteins and to determine whether cross-reactive epitopes were present in the BIV Gag precursors or processed products. The BIV MA, CA, and NC Gag proteins were identified as p16, p26, and p13, respectively. In addition to BIV Pr53gag, the major Gag precursor, two other Gag-related precursors of 170 and 49 kDa were identified that have been designated pPr170gag-pol and Pr49gag, respectively; pPr170gag-pol is the Gag-Pol polyprotein precursor, and Pr49gag is the transframe Gag precursor present in pPr170gag-pol. Several alternative Gag cleavage products were also observed, including p23, which contains CA and NC determinants, and p10, which contains a peptide sequence conserved in the CA proteins of most lentiviruses. The monospecific antisera to human immunodeficiency virus type 1 CA (p24) and NC (p7) proteins showed cross-reactivity to and aided in the identification of analogous BIV proteins. Based on the present data, a scheme for the processing of BIV Gag precursors is proposed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331499      PMCID: PMC240293     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

Review 2.  Fatty acylation of proteins.

Authors:  A M Schultz; L E Henderson; S Oroszlan
Journal:  Annu Rev Cell Biol       Date:  1988

3.  Nucleotide sequence of the AIDS virus, LAV.

Authors:  S Wain-Hobson; P Sonigo; O Danos; S Cole; M Alizon
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

4.  Molecular cloning of biologically active proviruses of bovine immunodeficiency-like virus.

Authors:  M J Braun; S Lahn; A L Boyd; T A Kost; K Nagashima; M A Gonda
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

5.  The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.

Authors:  R J Mervis; N Ahmad; E P Lillehoj; M G Raum; F H Salazar; H W Chan; S Venkatesan
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

6.  Comparative large-scale propagation of retroviruses from Old World (Mason-Pfizer monkey virus) and New World (squirrel monkey virus) primates.

Authors:  C V Benton; H M Hodge; D L Fine
Journal:  In Vitro       Date:  1978-02

7.  Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins.

Authors:  L E Henderson; R C Sowder; G W Smythers; S Oroszlan
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

8.  Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne).

Authors:  L E Henderson; R E Benveniste; R Sowder; T D Copeland; A M Schultz; S Oroszlan
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15.

Authors:  F D Veronese; R Rahman; T D Copeland; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  AIDS Res Hum Retroviruses       Date:  1987       Impact factor: 2.205

View more
  5 in total

1.  Construction and characterization of chimeric BHIV (BIV/HIV-1) viruses carrying the bovine immunodeficiency virus gag gene.

Authors:  Yi-Xin Zhu; Chang Liu; Xin-Lei Liu; Wen-Tao Qiao; Qi-Min Chen; Yi Zeng; Yun-Qi Geng
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

2.  Bovine immunodeficiency virus: a lentiviral infection.

Authors:  Sandeep Bhatia; S S Patil; R Sood
Journal:  Indian J Virol       Date:  2013-09-27

3.  Amino acid sequence analysis of the proteolytic cleavage products of the bovine immunodeficiency virus Gag precursor polypeptide.

Authors:  G J Tobin; R C Sowder; D Fabris; M Y Hu; J K Battles; C Fenselau; L E Henderson; M A Gonda
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

4.  Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.

Authors:  M I Anazodo; M A Wainberg; A D Friesen; J A Wright
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

5.  Characterization of bovine immunodeficiency virus rev cDNAs and identification and subcellular localization of the Rev protein.

Authors:  M S Oberste; J C Williamson; J D Greenwood; K Nagashima; T D Copeland; M A Gonda
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.